Natella Cherpanova Hinderberger

09/08/2026

Potential mechanisms for chorioamniotic membrane rupture after subchorionic hematoma https://ow.ly/j0uC50WyYx1

09/08/2026

09/08/2026

A preclinical inflammatory phase in amniotic fluid embolism: evidence from circulating cytokines https://ow.ly/jV0C50ZxnYr

30/07/2026

Histological outcomes and colposcopic findings in patients with persistent high-risk human papillomavirus infection without major cytological findings https://ow.ly/S9Yv50ZtJu7

08/07/2026

Double versus single emergency cervical cerclage combined with vaginal progesterone: a multicenter, non-blinded, randomized controlled trial https://ow.ly/ZyEq50ZltQz

02/07/2026

Serial amnioinfusions improved early survival in pregnancies complicated by # anhydramnios from fetal failure, achieving survival to 14 days and dialysis access in a substantial proportion of live births.

Survival to discharge was lower, and surviving infants faced considerable long-term morbidity, including the need for ongoing dialysis or kidney transplant.

Factors associated with better outcomes included higher birth weight, more amnioinfusions, later gestational age at delivery, and longer time before membrane rupture. The intervention demonstrated maternal feasibility but highlighted ongoing challenges in reducing neonatal morbidity and optimizing long-term care.

https://ja.ma/4vaxVYy

11/06/2026

Reducing the long-term impact of cesarean scar defects: a focus on prevention https://ow.ly/Knj650YUgMO

04/06/2026

Among women with cervical intraepithelial neoplasia or carcinoma in situ, cold knife conization was associated with a lower risk of recurrent cervical lesions and higher clearance rates compared with the loop electrosurgical excision procedure. https://ja.ma/4o5VO1n

06/05/2026

Pregnancy outcomes in heart transplant recipients: a systematic review and meta-analysis of maternal and neonatal morbidities https://ow.ly/1NQh50YUUUP

01/05/2026

Early studies by Cedars-Sinai Health Sciences University investigators tested a dialysis-like treatment to remove a harmful protein from the blood and help extend pregnancy in women with severe preeclampsia.

Cedars-Sinai researchers tested a new treatment for severe preeclampsia that lowered blood pressure, reduced harmful proteins and safely extended pregnancy.